37LOW

BOT

BOTANIX FPO [BOT]
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Healthcare · ASX Small Cap
$0.0410 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical53
Catalyst63
Sentiment50
Fundamental56
Momentum29
Risk Gate40
Get alerts when BOT's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track BOT — Free

Active Signals

Bullish Signals

  • RSI is looking oversold — historically a spot where stocks tend to bounce
  • MACD momentum is picking up steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Drifting lower — down 4.7% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.82, underperforming its peers
  • Critical cash runway (1.6 quarters)
  • Low P/S ratio (4.3x)
  • Strong revenue growth (+4271%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (0% of range)
  • Small-cap ($20-100M)
  • Substantial holder(s) ceased (1)
  • Capital raise activity (2 events)
  • Dilution velocity warning (2 raises recently)
  • CANSLIM I: Institutional ownership (16%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 85% over the past year
  • Poor risk-adjusted returns — Sharpe of -1.9 means lots of volatility for not much reward
  • Revenue growing at +4271% — the top line is moving in the right direction
  • Elevated dilution risk (2 recent capital raises)
  • Low-priced stock risk ($0.042)
  • Beneish M-Score 1.20 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-7.10%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about BOT
"What's driving BOT's score?" "How does BOT compare to peers?" "Key risks for BOT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

LOW Botanix Presents at Euroz Hartleys Institutional Conference
HIGH Ceasing to be a substantial holder from IFL
NONE Release of Shares from Escrow
NONE Update - Proposed issue of securities - BOT
NONE Update - Proposed issue of securities - BOT

Recent ASX Announcements

2026-03-17 Botanix Presents at Euroz Hartleys Institutional Conference
2026-03-17 Ceasing to be a substantial holder from IFL
2026-03-13 Release of Shares from Escrow
2026-03-10 Update - Proposed issue of securities - BOT
2026-03-10 Update - Proposed issue of securities - BOT

Key Metrics

$93.2M
Market Cap
15.9M
Avg Volume
1.7x
Vol Ratio
$0.04 — $0.48
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
-121.1%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 78%
LLeader vs LaggardlaggardRS: -16
IInstitutional SponsorshippassInst: 16%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #100 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:BOT vs ATXBOT vs PNVBOT vs IMM
Scout Pro — Deeper Analysis for BOT
Try Pro free for 30 days
Share this analysis

Track BOT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required